Can Sionna Therapeutics, Inc. Common Stock cover its short-term obligations?

Its current ratio is 22.60 — current assets exceed current liabilities.

Where does Sionna Therapeutics, Inc. Common Stock's balance sheet data come from?

Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Sionna Therapeutics, Inc. Common Stock SION Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$64.29M+8.2%	$59.41M+14.7%	$51.79M+23.5%	$41.95M-49.9%	$83.66M+116%
Total current assets	$220.96M-8.5%	$241.42M-4.3%	$252.33M—	——	——
Property and equipment, net	$2.07M-6.9%	$2.23M+3.8%	$2.14M—	——	——
Long-term investments	$73.78M-0.9%	$74.42M-2.9%	$76.67M—	——	——
Total assets	$305.04M-6.4%	$325.95M-3.9%	$339.27M—	——	——
Accounts payable	$5.27M-35.6%	$8.18M-4.8%	$8.6M+60.5%	$5.36M—	——
Total current liabilities	$9.78M-16.5%	$11.71M+18.9%	$9.85M—	——	——
Total liabilities	$16.83M-12.0%	$19.12M+8.6%	$17.6M—	——	——
Common stock	500M0.0%	500M0.0%	500M—	——	——
Retained earnings	-$283.13M-10.4%	-$256.35M-8.7%	-$235.91M—	——	——
Total stockholders' equity	$288.21M-6.1%	$306.83M-4.6%	$321.67M-4.4%	$336.43M-4.4%	$351.77M+315%
Total liabilities and stockholders' equity	$305.04M-6.4%	$325.95M-3.9%	$339.27M—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Sionna Therapeutics, Inc. Common Stock cover its short-term obligations?: Its current ratio is 22.60 — current assets exceed current liabilities.
Where does Sionna Therapeutics, Inc. Common Stock's balance sheet data come from?: Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.